1352152-68-1

Basic information

• Product Name: 5-bromo-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide
• Synonyms: 5-bromo-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide;5-Bromo-2,3-Dihydro-Benzo[D]Isothiazole 1,1-Dioxide(WX633124)
• CAS NO: 1352152-68-1
• Molecular Formula: C₇H₆BrNO₂S
• Molecular Weight: 248.09704
• Mol File: 1352152-68-1.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 371.1±52.0 °C(Predicted)
• Appearance: /
• Density: 1.806±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 10.45±0.20(Predicted)
• CAS DataBase Reference: 5-bromo-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide(1352152-68-1)
• EPA Substance Registry System: 5-bromo-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide(1352152-68-1)

Safety Data

• Hazardous Substances Data: 1352152-68-1(Hazardous Substances Data)

Upstream product

• 116340-67-1 4-bromo-2-methyl-benzenesulfonamide 
• 1261758-91-1 C₇H₇Br₂NO₂S 
• 1607838-25-4 5-bromo-2-(tert-butyl)-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide 
• 591-17-3 meta-bromotoluene 
• 139937-37-4 5-bromo-2-toluenesulfonyl chloride 
• 29632-82-4 5-bromo-1,1-dioxo-1,2-dihydro-1λ6-benzo[d]isothiazol-3-one 

Downstream Products

• 1352152-67-0 N-α-({1-[(tert-butoxycarbonyl)amino]cyclohexyl}carbonyl)-4-(1,1-dioxo-2,3-dihydro-1,2-benzisothiazol-5-yl)-L-phenylalaninamide 
• 1607838-28-7 8-[2-[bis-(4-methoxybenzyl)amino]-3-chloro-5-(2-ethyl-1,1-dioxo-2,3-dihydro-1H-benzo[d]isothiazol-5-yl)pyridin-4-yl]-2,8-diazaspiro[4.5]decan-1-one 
• 1254319-63-5 5-bromo-2-(methyl)-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide 

Relevant articles and documents

BICYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS

Provided herein are compounds, compositions including them, and methods of modulating GPR120 activity and treating diseases mediated by GPR120 by administering such compounds and compositions.

PYRIDYL PIPERIDINES

The invention provides novel substituted pyridyl piperidine compounds according to Formula (I) which are Wnt pathway inhibitors, their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.

GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS

The instant invention provides compounds of Formula (I) which are JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.